Skip to content
Location
Online Event
Series/Type
Dates
  • November 15, 2021 from 12:00pm to 1:00pm

Links

Special note: This seminar will be hosted on Zoom. Please register to receive the link and password two hours before the seminar. Please note that space is limited.

This seminar is co-hosted by the Centre for Vaccine Preventable Diseases, the Global Public Health and Health Systems Improvement through Implementation Science Cluster, and the Centre for Global Health, at the Dalla Lana School of Public Health, University of Toronto.

Speakers: Archchun Ariyarajah, Isha Berry, Victoria Haldane, and Miranda Loutet of the COVID Vaccine Consensus (CVC) Working Group

Title: Delivery of COVID-19 vaccines in low- and middle-income countries: a Delphi survey to identify implementation barriers and enablers

Topic: The COVID-19 pandemic has exacerbated pre-existing challenges to health promotion and care across the world, and particularly in low- and middle-income countries (LMICs). There continues to be a lack of consensus on the primary challenges and solutions to implementation of delivery programs for COVID-19 vaccines globally. A better understanding of implementation barriers and enablers attendant to novel vaccine delivery will provide important direction for policymakers, multilateral agencies, and health care providers to ensure that COVID-19 vaccines are effectively and equitably delivered. We present interim results from our Delphi study which aims to identify and gain consensus among a diverse group of topic experts on the key challenges to COVID-19 vaccine implementation programmes in LMICs as well as potential solutions. Ultimately, this research can be used to inform a road map to improve targeted COVID-19 vaccine roll-out globally.

Presenter Bios:

The COVID Vaccine Consensus (CVC) Working Group is composed of DLSPH and IHPME PhD students in epidemiology and health services research (HSR), and is supervised by Dr. Ross Upshur. CVC members bring a breadth of research experience, with a focus on infectious diseases in low- and middle-income settings.

Archchun Ariyarajah researches vaccine-preventable diseases. He has experience in outbreak response with the WHO in Sierra Leone and Haiti. As an IS trainee he is interested in implementation barriers to vaccination.

Isha Berry researches emerging infectious diseases in South Asia. Her research leverages digital technology for health surveillance, including monitoring COVID-19 in Canada. As an IS trainee she is interested in translating research into policy.

Victoria Haldane researches implementation science for infectious disease programs. She has experience conducting health systems research in Southeast Asia, including measuring COVID-19 impacts. As an IS trainee she is interested in how context shapes program outcomes.

Miranda Loutet researches maternal and child health in Bangladesh. She has experience in public health and clinical infectious disease research across global settings. As an IS trainee she is interested in implementing impactful and sustainable health programs.

About the Centre for Vaccine Preventable Diseases, DLSPH:

With leadership housed at the University of Toronto’s Dalla Lana School of Public Health, we are developing an interdisciplinary group of academic researchers, educators and public health advocates. Our vision is to catalyze cutting-edge research and education that maximizes the health benefits of immunization for everyone.

We aim to contribute locally and globally to healthy communities through excellence in interdisciplinary vaccine-preventable disease and immunization research and education.

Questions? Email us at cvpd.dlsph@utoronto.ca